Skip to main content

Eli Lilly’s stock rises as results beat expectations, Mounjaro sales surge

Mounjaro revenues beat lofty expectations as Lilly realizes higher prices in the U.S.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.